跳至主要内容
临床试验/NCT00710203
NCT00710203已完成不适用

Efficacy of a 585 nm Pulsed Dye Laser (PDL) for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.

University of California, Davis1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2008年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Percent Clearance of All Lesions

研究概览

简要总结

DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face.

The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Over 18 years of age.
  • •Able to give informed consent.
  • •Desires removal of lesions.
  • •Willing to come back for six week follow-up.
  • •Willing to fill out post operative questionnaire.
  • •At least 4 lesions less than 7 mm.
  • •Diagnosis of Dermatosis Papulosa Nigra (DPN)

排除标准

  • •Less than 18 years of age.
  • •Pregnant.
  • •Sensitive to laser energy.
  • •History of Collagen Vascular Disorders.
  • •History of Keloids.
  • •History of post inflammatory hyperpigmentation.
  • •Incarcerated.
  • •Unable to give informed consent.
  • •Unable to follow up for post operative evaluation.
  • •Unable to complete patient visual analogue scale.
  • •Unable to understand consent process or risks.
  • •Unable to accept risk of scar, infection, minor bleeding, permanent or prolonged hyperpigmentation and hypopigmentation.

研究组 & 干预措施

Pulsed dye laser

Active Comparator

Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.

干预措施: Pulsed dye laser (Device)

Curettage

Active Comparator

Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.

干预措施: Curettage (Procedure)

Electrodesiccation

Active Comparator

Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.

干预措施: Electrodesiccation (Procedure)

No treatment

Active Comparator

Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.

干预措施: No treatment (Other)

结局指标

主要结局

Percent Clearance of All Lesions

时间窗: 6 to 12 weeks

The physician assessed percent clearance of all treated lesions and the control lesion.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验